CD8A and neoplasm: These results indicate that the BAY-I induced T cell-inflamed phenotype can persist for at least 10 weeks after drug withdrawal, and is likely maintained by intratumoral clonal expansion of tumor specific CD8+ T cells, rather than recruitment from the circulation.